RIGI and cancer: ML-60218 treatment had no effect on the Poly(dA:dT)-induced IFN-β expression in human cancer cells (Supplementary Figures 3A,B) but significantly inhibited this expression in the 293T cells (Supplementary Figure 3C), indicating that RNA polymerase III is not involved in the RIG-I signaling pathway in human cancer cells.